乳腺癌患者抑郁症状的非药物干预:系统审查和网络元分析协议
Ping Yin1, Lumin Liu1, Ningyang Gao2
1Sleep Medicine Center, LongHua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China.
BMJ open
|June 4, 2024
概括
本研究将使用网络元分析对乳腺癌患者减轻抑郁症的非药物干预措施进行比较. 它旨在客观地评估这些疗法的疗效和安全性,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 精神病学是一个精神病学.
- 基于证据的医学 基于证据的医学
背景情况:
- 乳腺癌患者经常出现抑郁症状,对生活质量和治疗产生负面影响.
- 心理治疗,心身疗法和运动等非药物干预措施对与癌症有关的抑郁症有很大的前景.
- 这些干预措施的比较有效性和安全性需要客观评估.
研究的目的:
- 进行网络元分析 (NMA),比较乳腺癌患者的各种非药物干预措施.
- 客观地评估不同非药物治疗对减轻抑郁症状的影响.
- 为乳腺癌护理中最佳的非药物治疗选择提供证据.
主要方法:
- 系统搜索9个中英数据库,查找随机对照试验,截至2023年7月31日.
- 由两个独立研究人员提取信息,重点关注抑郁症症状变化和不良事件.
- 使用STATA V.15.0进行网络元分析,通过GRADE评估质量,通过Cochrane工具V.2.评估偏差风险.
主要成果:
- 本部分应在研究完成后填写.
结论:
- 本部分应在研究完成后填写.
更多相关视频
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
1.0K
06:26Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI
Published on: November 27, 2019
70.6K
相关概念视频
Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
2.2K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
2.2K
Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220
